These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1763202
1. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. Sakuma Y, Tsunoda H, Shirato M, Katayama S, Yamatsu I, Katayama K. Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202 [Abstract] [Full Text] [Related]
2. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice. Sakuma Y, Muramoto K, Harada K, Katayama S, Tsunoda H, Katayama K. Prostaglandins; 1991 Dec; 42(6):541-55. PubMed ID: 1801063 [Abstract] [Full Text] [Related]
3. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K. Agents Actions Suppl; 1990 Dec; 31():251-4. PubMed ID: 2080757 [Abstract] [Full Text] [Related]
4. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K. Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [Abstract] [Full Text] [Related]
5. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation. Tsunoda H, Sakuma Y, Shirato M, Obaishi H, Harada K, Yamada K, Shimomura N, Machida Y, Yamatsu I, Katayama K. Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658 [Abstract] [Full Text] [Related]
6. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M. Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [Abstract] [Full Text] [Related]
7. Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. Sakuma Y, Tsunoda H, Katayama S, Harada K, Obaishi H, Shirato M, Yamada K, Miyazawa S, Okano K, Machida Y. Agents Actions Suppl; 1990 May; 31():255-8. PubMed ID: 2080758 [Abstract] [Full Text] [Related]
9. Involvement of PAF in postallergic propranolol-induced bronchoconstriction in guinea-pigs. Fujimura M, Tsujiura M, Songür N, Myou S, Matsuda T. Eur Respir J; 1996 Oct; 9(10):2064-9. PubMed ID: 8902468 [Abstract] [Full Text] [Related]
10. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis. Sakuma Y, Shirato M, Nagaoka J, Obaishi H, Tsunoda H, Katayama S, Ono H, Katayama K. Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526 [Abstract] [Full Text] [Related]
11. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G. J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029 [Abstract] [Full Text] [Related]
12. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor. Terasawa M, Aratani H, Setoguchi M, Tahara T. Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935 [Abstract] [Full Text] [Related]
13. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs. Kaneko T, Ikeda H, Fu L, Nishiyama H, Okubo T. Eur J Pharmacol; 1995 Mar 16; 292(3-4):251-5. PubMed ID: 7796863 [Abstract] [Full Text] [Related]
14. RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo. Underwood SL, Lewis SA, Raeburn D. Pulm Pharmacol; 1992 Sep 16; 5(3):203-12. PubMed ID: 1280178 [Abstract] [Full Text] [Related]
15. The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration. Seeds EA, Coyle AJ, Page CP. J Lipid Mediat; 1991 Sep 16; 4(1):111-21. PubMed ID: 1893085 [Abstract] [Full Text] [Related]
16. Structure-activity studies on triazolothienodiazepine derivatives as platelet-activating factor antagonists. Miyazawa S, Okano K, Shimomura N, Clark RS, Kawahara T, Asano O, Yoshimura H, Miyamoto M, Sakuma Y, Muramoto K. Chem Pharm Bull (Tokyo); 1991 Dec 16; 39(12):3215-20. PubMed ID: 1814614 [Abstract] [Full Text] [Related]
17. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs. Perretti F, Manzini S. Am Rev Respir Dis; 1993 Oct 16; 148(4 Pt 1):927-31. PubMed ID: 7692777 [Abstract] [Full Text] [Related]
18. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. Heuer HO. J Lipid Mediat; 1991 Oct 16; 4(1):39-44. PubMed ID: 1893086 [Abstract] [Full Text] [Related]
19. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. J Pharmacol Exp Ther; 1990 Dec 16; 255(3):962-8. PubMed ID: 2262914 [Abstract] [Full Text] [Related]
20. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs. Iwahisa Y, Yamaguchi S, Kagoshima M, Terasawa M. Jpn J Pharmacol; 1996 Nov 16; 72(3):209-15. PubMed ID: 8957681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]